Semenov_2022_Molecules_27_

Reference

Title : Novel Uracil-Based Inhibitors of Acetylcholinesterase with Potency for Treating Memory Impairment in an Animal Model of Alzheimer's Disease - Semenov_2022_Molecules_27_
Author(s) : Semenov VE , Zueva IV , Lushchekina SV , Suleimanov EG , Gubaidullina LM , Shulaeva MM , Lenina OA , Petrov KA
Ref : Molecules , 27 : , 2022
Abstract :

Novel derivatives based on 6-methyluracil and condensed uracil, 2,4-quinazoline-2,4-dione, were synthesized with terminal meta- and para-benzoate moieties in polymethylene chains at the N atoms of the pyrimidine ring. In the synthesized compounds, the polymethylene chains were varied from having tris- to hexamethylene chains and quaternary ammonium groups; varying substituents (ester, salt, acid) at benzene ring were introduced into the chains and benzoate moieties. In vivo biological experiments demonstrated the potency of these compounds in decreasing the number of beta-amyloid plaques and their suitability for the treatment of memory impairment in a transgenic model of Alzheimer's disease.

PubMedSearch : Semenov_2022_Molecules_27_
PubMedID: 36431954

Related information

Citations formats

Semenov VE, Zueva IV, Lushchekina SV, Suleimanov EG, Gubaidullina LM, Shulaeva MM, Lenina OA, Petrov KA (2022)
Novel Uracil-Based Inhibitors of Acetylcholinesterase with Potency for Treating Memory Impairment in an Animal Model of Alzheimer's Disease
Molecules 27 :

Semenov VE, Zueva IV, Lushchekina SV, Suleimanov EG, Gubaidullina LM, Shulaeva MM, Lenina OA, Petrov KA (2022)
Molecules 27 :